Literature DB >> 15734434

Antihuman factor V antibodies after use of relatively pure bovine thrombin.

Jeffrey H Lawson1, Kellie A Lynn, Reed M Vanmatre, Taymon Domzalski, Keith F Klemp, Thomas L Ortel, Laura E Niklason, William Parker.   

Abstract

Although bovine thrombin is commonly used in the operating room, there is evidence that exposure to bovine thrombin can result in the development of autoimmune antibodies, usually against factor V, which can lead to a profound coagulopathy. It is thought that impurities in bovine thrombin preparations are responsible for the adverse reactions in patients. Here we describe a case in which exposure to a relatively pure bovine thrombin preparation resulted in the development of an antihuman factor V antibody-associated coagulopathy. This report calls into question the safety of even relatively pure bovine thrombin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15734434     DOI: 10.1016/j.athoracsur.2003.09.110

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  11 in total

1.  The long term immunological response of swine after two exposures to a salmon thrombin and fibrinogen hemostatic bandage.

Authors:  Stephen W Rothwell; Timothy Settle; Shannon Wallace; Jennifer Dorsey; David Simpson; James R Bowman; Paul Janmey; Evelyn Sawyer
Journal:  Biologicals       Date:  2010-08-11       Impact factor: 1.856

Review 2.  Advances in the surgical management of chronic sinusitis and nasal polyps.

Authors:  Vijay R Ramakrishnan; David W Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

3.  Wound healing and the immune response in swine treated with a hemostatic bandage composed of salmon thrombin and fibrinogen.

Authors:  Stephen W Rothwell; Evelyn Sawyer; Jennifer Dorsey; William S Flournoy; Timothy Settle; David Simpson; Gary Cadd; Paul Janmey; Charles White; Kathleen A Szabo
Journal:  J Mater Sci Mater Med       Date:  2009-05-18       Impact factor: 3.896

4.  Safety of topical thrombins: the ongoing debate.

Authors:  Christopher Lomax
Journal:  Patient Saf Surg       Date:  2009-09-04

5.  Thrombin use in surgery: an evidence-based review of its clinical use.

Authors:  Sung W Ham; Wesley K Lew; Fred A Weaver
Journal:  J Blood Med       Date:  2010-07-22

6.  The unresolved safety concerns of bovine thrombin.

Authors:  Aryeh Shander; Mazyar Javidroozi
Journal:  Patient Saf Surg       Date:  2008-09-22

7.  Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety.

Authors:  Paul Ness; Michael Creer; George M Rodgers; Joseph J Naoum; Kenneth Renkens; Stacy A Voils; W Allan Alexander
Journal:  Patient Saf Surg       Date:  2009-05-22

8.  Clinical use of topical thrombin as a surgical hemostat.

Authors:  Wesley K Lew; Fred A Weaver
Journal:  Biologics       Date:  2008-12

9.  Comparison of two gelatin and thrombin combination hemostats in a porcine liver abrasion model.

Authors:  Kevin M Lewis; Holly D Atlee; Angela J Mannone; Joseph Dwyer; Lawrence Lin; Andreas Goppelt; Heinz Redl
Journal:  J Invest Surg       Date:  2013-03-20       Impact factor: 2.533

Review 10.  Topical biomaterials to prevent post-tonsillectomy hemorrhage.

Authors:  Lumei Liu; Cole Rodman; Noah E Worobetz; Jed Johnson; Charles Elmaraghy; Tendy Chiang
Journal:  J Otolaryngol Head Neck Surg       Date:  2019-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.